蕾明视康 develops and manufactures intraocular lenses using self‑developed high‑refractive‑index, hydrophobic acrylate materials and multiple IOL product lines. Its RS-series aspheric IOL obtained an EU CE certificate in 2016 and CFDA approval in June 2017, and the company has filed multiple domestic and international (PCT) patent applications. The team is led by Dr. 廖秀高 (a Thousand Talents program member) and includes experts in materials science, ophthalmology, optics, and engineering. The company operates a raw‑materials factory in Irvine, USA, and sells products to markets including the United States and France. Future plans emphasize continued layout of mid‑to‑high‑end foldable IOLs, product innovation to better match Chinese patients, and import substitution to build a domestic brand.

Total raised

$13M

Funding rounds

1

Latest round

Series B

Latest activity

May 2018